FindTrial
Sign In

Clinical study on changes in sex hormone levels and bone mass after ovarian cancer surgery

Clinical study on changes in sex hormone levels and bone mass after ovarian cancer surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108443
Enrollment
Unknown
Registered
2025-08-29
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnosed

Interventions

Control qroup:None
Study group:None

Sponsors

Yuebei People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Diagnosed with ovarian cancer; 2. Standardized surgical treatment for ovarian cancer; 3. The survival period is greater than 2 years.

Exclusion criteria

Exclusion criteria: 1.There are congenital bone metabolism disorders, immune disorders of the bone and joint system, and use of hormone replacement therapy.

Design outcomes

Primary

MeasureTime frame
Hormone levels , ;Bone density values;—

Countries

China

Contacts

Public ContactYu Ping

Yuebei People’s Hospital

yuping15236@126.com+86 18127679569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026